TY - JOUR
T1 - Functional Impairments in a Patient with Morvan Syndrome
T2 - A Case Presentation
AU - Tow, Stephanie
AU - Carozza, Desi
AU - Barker, Kim
N1 - Publisher Copyright:
© 2018 American Academy of Physical Medicine and Rehabilitation
PY - 2018/7
Y1 - 2018/7
N2 - A 48-year-old man with lung squamous cell carcinoma was admitted to acute care with cognitive impairment after recent chemotherapy. He developed myoclonus, ataxia, agitation, and visual hallucinations. Morvan syndrome, a rare voltage-gated potassium channel antibody disorder characterized by neuromyotonia with central nervous system dysfunction, was eventually diagnosed. He received plasmapheresis and was admitted to inpatient rehabilitation, where he safely participated in therapies. By focusing on neuromuscular rehabilitation, balance training, fine motor skills, and cognitive retraining emphasizing skills relevant to the patient's premorbid cognitive activities, the patient demonstrated significant functional improvement, decreasing the burden of care of his caregivers.
AB - A 48-year-old man with lung squamous cell carcinoma was admitted to acute care with cognitive impairment after recent chemotherapy. He developed myoclonus, ataxia, agitation, and visual hallucinations. Morvan syndrome, a rare voltage-gated potassium channel antibody disorder characterized by neuromyotonia with central nervous system dysfunction, was eventually diagnosed. He received plasmapheresis and was admitted to inpatient rehabilitation, where he safely participated in therapies. By focusing on neuromuscular rehabilitation, balance training, fine motor skills, and cognitive retraining emphasizing skills relevant to the patient's premorbid cognitive activities, the patient demonstrated significant functional improvement, decreasing the burden of care of his caregivers.
UR - http://www.scopus.com/inward/record.url?scp=85047343207&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047343207&partnerID=8YFLogxK
U2 - 10.1016/j.pmrj.2017.10.014
DO - 10.1016/j.pmrj.2017.10.014
M3 - Article
C2 - 29222073
AN - SCOPUS:85047343207
SN - 1934-1482
VL - 10
SP - 766
EP - 769
JO - PM and R
JF - PM and R
IS - 7
ER -